KRAS Mutation in Serous Borderline Tumor of the Testis: Report of a Case and Review of the Literature

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td class="align_left">AKT1</td><td class="align_center">DICER1</td><td class="align_center">FOXL2</td><td class="align_center">POLE</td></tr><tr><td class="align_left">BRAF</td><td class="align_center">ERBB2</td><td class="align_center">KRAS</td><td class="align_center">PTEN</td></tr><tr><td class="align_left">CDKN2A</td><td class="align_center">FBXW7</td><td class="align_center">PIK3CA</td><td class="align_center">RB1</td></tr><tr><td class="align_left">CTNNB1</td><td class="align_center">FGFR2</td><td class="align_center">PIK3R1</td><td class="align_center">TP53</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Cancer hotspot panel used by next-generation sequencing.</div>

Case Reports in Urology

tab1

Table 1

Table 1: KRAS Mutation in Serous Borderline Tumor of the Testis: Report of a Case and Review of the Literature 